Bio-Me has received 2 million Euro in grants and public support from The Research Council of Norway to develop a companion diagnostic test for immune checkpoint inhibitor cancer treatments.
...
Bio-Me is one of the participants in a new Nordic project that will develop personalized treatment for IBD patients.
...
Bio-Me, a pioneer in rapid gut microbiome analysis is announcing the opening of its gut microbiome analysis service laboratory.
...
Bio-Me has entered into an agreement with one of the top ten consumer healthcare companies worldwide.
...
Dr. Morten Isaksen, CEO of Bio-Me, has been invited to present Bio-Me and its contribution to use of information from the gut microbiome in clinical settings.
...
Morten Isaksen, CEO of Bio-Me, is featured on LØRN, leading Norwegian technology blog and podcast service.
...
Bio-Me is pleased to announce that it has been selected as the recipient of Aleap Pre-Seed Fund.
...
After a globally competitive process spanning two months, Bio-Me was selected as one of twelve companies to be part of Katapult Accelerator (KA) Batch 3....
INNOMAG, the leading innovation magazine in Norway, has selected Bio-Me as one of the 25 most innovative new companies in Norway in 2018....
The conference brings together leaders and executives from the pharmaceutical, biotech, academic, and government communities....
